GlassScriptPhysician profile
Christopher I Loewe
NPI 1518913557
$425.82
in general payments reported to CMS, 2019-2025
7 companies · $14.09 in 2025
The $14.09 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.81 · 2021: $117 · 2022: $219 · 2025: $14.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $124.98 | 2022 | |
| Inari Medical, INC. | $117.09 | 2021 | |
| Boston Scientific Corporation | $93.85 | 2022 | |
| Janssen Pharmaceuticals, INC | $37.21 | 2019 | |
| Csl Behring | $26.77 | 2019 | |
| Genentech USA, INC. | $14.09 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $11.83 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Loewe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.